Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.800
+0.020 (1.12%)
At close: Mar 27, 2026
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 177.81 million as of March 27, 2026. Its market cap has increased by 40.92% in one year.
Market Cap
177.81M
Enterprise Value
196.09M
Revenue
112.25M
Ranking
n/a
PE Ratio
15.10
Stock Price
1.80
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 177.81M, a decrease of -15.98%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 177.81M | 7.58% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 286.94M |
| Aurora Cannabis | 262.00M |
| Organigram Global | 248.13M |
| Auxly Cannabis Group | 203.73M |
| BioSyent | 167.98M |
| Cardiol Therapeutics | 166.41M |
| Charlotte's Web Holdings | 159.68M |
| HLS Therapeutics | 137.29M |